Giulia Scartabellati
Brescia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Adiposity Excess and Vertebral Fractures in Patients With Breast Cancer Taking Aromatase Inhibitors.
Adiposity Excess and Vertebral Fractures in Patients With Breast Cancer Taking Aromatase Inhibitors.
Journal: JAMA network open
Published: July 30, 2026
Circulating tumor cells predict early skeletal-related events in patients with bone metastases from breast cancer.
Journal: The journal of liquid biopsy
Published: May 21, 2026
Prolonged survival in a HER2 positive metastatic breast cancer patient with brain metastases treated with TDM1 after failure of next generation HER2 targeted therapies: case report.
Journal: Frontiers in oncology
Published: April 26, 2026
Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy.
Journal: Breast cancer research and treatment
Published: April 14, 2025
Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data.
Journal: International journal of molecular sciences
Published: July 31, 2023
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?
Journal: Expert review of anticancer therapy
Published: April 05, 2023
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
Journal: Anti-cancer drugs
Published: December 20, 2022
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study.
Journal: Therapeutic advances in urology
Published: July 12, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026